MEDICINES CO's ticker is MDCO and the CUSIP is 584688105. A total of 210 filers reported holding MEDICINES CO in Q2 2017. The put-call ratio across all filers is 0.72 and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $34,750,000 | -9.0% | 409,112 | -46.5% | 0.10% | -12.8% |
Q3 2019 | $38,201,000 | +119.0% | 764,012 | +59.7% | 0.11% | +131.9% |
Q2 2019 | $17,446,000 | +26.6% | 478,373 | -2.9% | 0.05% | +27.0% |
Q1 2019 | $13,776,000 | +61.0% | 492,873 | +10.3% | 0.04% | +48.0% |
Q4 2018 | $8,556,000 | -18.9% | 447,035 | +26.7% | 0.02% | -7.4% |
Q3 2018 | $10,554,000 | -18.5% | 352,868 | 0.0% | 0.03% | -15.6% |
Q2 2018 | $12,950,000 | -15.6% | 352,868 | -24.3% | 0.03% | -15.8% |
Q1 2018 | $15,346,000 | +20.5% | 465,863 | 0.0% | 0.04% | +26.7% |
Q4 2017 | $12,737,000 | -26.2% | 465,863 | 0.0% | 0.03% | -23.1% |
Q3 2017 | $17,256,000 | -42.5% | 465,863 | -41.0% | 0.04% | -45.8% |
Q2 2017 | $29,990,000 | -38.1% | 789,014 | -20.4% | 0.07% | -40.0% |
Q1 2017 | $48,455,000 | +35.3% | 990,899 | -6.1% | 0.12% | +31.9% |
Q4 2016 | $35,808,000 | -7.0% | 1,055,029 | +3.4% | 0.09% | -6.2% |
Q3 2016 | $38,519,000 | +106.3% | 1,020,629 | +83.9% | 0.10% | +102.1% |
Q2 2016 | $18,668,000 | – | 555,099 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sarissa Capital Management LP | 4,202,000 | $356,917,000 | 29.62% |
SYQUANT CAPITAL SAS | 505,030 | $42,897,000 | 22.09% |
Moab Capital Partners | 521,987 | $44,338,000 | 17.51% |
Antipodean Advisors LLC | 321,000 | $27,266,000 | 15.60% |
RAMIUS ADVISORS LLC | 419,826 | $35,660,000 | 15.34% |
DLD Asset Management, LP | 3,275,900 | $278,255,000 | 15.00% |
Foresite Capital Management IV, LLC | 403,217 | $34,249,000 | 14.78% |
WHITE SQUARE CAPITAL LLP | 239,331 | $20,329,000 | 14.70% |
Davide Leone & Partners Investment Co Ltd. | 1,146,192 | $97,358,000 | 12.50% |
Quad Capital Management Advisors LLC | 8,640 | $734,000 | 11.19% |